Traditional diagnostic microbiology operates like a smoke detector: it looks for a clear, unmistakable sign of a fire. When a clinician cultures a sample and a specific bacterium grows, the physical presence of replicating colonies provides strong evidence of an active, living agent.
Modern molecular diagnostics—such as metagenomic next-generation sequencing (mNGS), nanopore sequencing, and targeted amplicon sequencing (TAS)—operate more like ultra-sensitive heat sensors. They can detect a single thermal spark from across a room. While this extreme sensitivity allows for rapid, "pan-pathogen" detection when traditional cultures fail (as demonstrated by Huili Shen et al. in Case report: The clinical utility of metagenomic next-generation sequencing in mucormycosis diagnosis caused by fatal Lichtheimia ramosa infection in pediatric neuroblastoma), it introduces a profound clinical dilemma: detecting microbial DNA is not the same as diagnosing an active disease.
Because these tools amplify trace fragments of nucleic acids, they routinely capture background biological noise. To make sequencing data actionable, researchers and clinicians must distinguish true pathogenic infection from three distinct categories of microbial noise: commensal colonization, environmental contamination, and non-viable cellular debris.
The Three Dimensions of Microbial Noise
1. Commensal Colonization
The human body is a complex ecosystem, and many anatomical sites once considered sterile are naturally inhabited by microbes. For example, Xiaoxing Li et al. demonstrated in Bacterial Microbiota Profiling in Gastritis without Helicobacter pylori Infection or Non-Steroidal Anti-Inflammatory Drug Use that the stomach hosts a diverse microbial community even in the absence of known pathogens.
When high-sensitivity sequencing is applied to non-sterile sites like the respiratory tract, it inevitably captures these harmless residents. In studies of severe pneumonia and bronchiectasis, Dongfeng Shen et al. (Association between Clinical Characteristics and Microbiota in Bronchiectasis Patients Based on Metagenomic Next-Generation Sequencing Technology) and the author Na Gao (Comparison of bronchoalveolar lavage fluid mNGS and sputum culture in the clinical application of severe pneumonia) note that mNGS frequently detects commensal or colonizing organisms that do not contribute to active disease. Similarly, the author Wei Li observed in Characteristics of adults with influenza A virus pneumonia and co-infections identified by mNGS in Jilin, China during 2024–2025 that the sheer volume of microbes detected makes it difficult to separate benign colonizers from true secondary pathogens, creating diagnostic ambiguity that can lead to antibiotic over-treatment.
2. Environmental and Sampling Contamination
Because molecular techniques amplify minute quantities of DNA, they are highly vulnerable to external contamination introduced during sample collection or laboratory processing.
- In vivo contamination: Medical devices can introduce noise before a sample is even taken. Kathleen Chiotos et al. showed in Indications for and Utility of Tracheal Aspirate Cultures for the Diagnosis of VAI that breathing tubes in mechanically ventilated patients quickly become colonized with bacteria, meaning tracheal cultures often capture device-associated colonization rather than a true lung infection. Similarly, Nandi Niemand Wolhuter et al. found in Contamination rates in serially sampled sputum specimens obtained during tuberculosis treatment to capture culture conversion that non-target microbial growth triples over the course of longitudinal sputum sampling, confounding the tracking of treatment progress.
- In vitro contamination: In the laboratory, ultra-sensitive assays can generate false positives from trace cross-contamination. Wen Jian et al. demonstrated in Rare Detection of Occult Hepatitis B Virus Infection in Children of Mothers with Positive Hepatitis B Surface Antigen that previously reported high rates of occult infections were actually artifacts of laboratory cross-contamination, which could only be ruled out by rigorous sequence homology filtering. When sequencing uncovers ubiquitous environmental organisms, clinicians face a paradox: Shengqiao Shi et al. note in Adjunctive Diagnosis of Mycobacterium gordonae Pneumonia by Metagenomic Next-Generation Sequencing in an Immunocompetent Patient: A Case Report and Literature Review that rare pathogens are often prematurely dismissed as laboratory artifacts, while Dan Li et al. emphasize in Case Report: Nanopore Sequencing-Based Detection of Pulmonary Nocardiosis Caused by Nocardia Otitidiscaviarum in an Immunocompetent Patient that environmental noise must be strictly cross-referenced with clinical symptoms to avoid false positives.
3. Microbial Viability Ambiguity
DNA is a highly stable molecule that can persist in an environment long after the source cell has died. Shotgun sequencing reads genetic material indiscriminately, meaning it cannot distinguish between a living, replicating pathogen and inert biological debris.
This limitation complicates risk assessment on environmental surfaces, such as in ambulances (Metagenomic characterization of ambulances across the USA by Niamh B. O’Hara et al.), where detected pathogen DNA may not represent a viable infectious threat. It creates identical challenges inside the human body. In blood metagenomics, Rongqiu Zhang et al. point out in Metagenomic analysis of blood microbiota alterations: insights into HIV progression and immune restoration that it is currently impossible to determine whether circulating microbial signatures represent active systemic threats or merely dead fragments from past translocation events. This viability ambiguity limits our understanding of the functional role of the blood microbiome in conditions like myeloid malignancies (Jakob Woerner et al. in Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes) and pediatric lung infections (Yingying Luo et al. in Differences in pulmonary microbiota of severe community-acquired pneumonia with different pathogenic microorganisms in children).
Resolving the Ambiguity
To transform high-sensitivity sequencing from a source of diagnostic noise into a precise clinical tool, researchers are developing frameworks to separate background signals from active infections.
[Microbial DNA Detected]
│
├───► Is the read count above the pathogen-specific threshold?
│ ├───► NO: Likely background noise / contamination
│ └───► YES: Proceed to host context
│
└───► Is the host immune response actively triggered?
├───► NO: Likely benign colonization
└───► YES: Confirmed active infection
Quantitative Thresholding
The simplest way to separate signal from noise is by establishing mathematical cutoffs for sequence reads. If a microbe is merely colonizing a tissue or introduced as a contaminant, its relative abundance will typically remain low. If it is actively causing an infection, it will replicate and dominate the sequence pool.
In Differentiation of Pneumocystis jirovecii pneumonia from colonization: a clinical decision framework incorporating risk stratification and next-generation sequencing thresholds, Peng Zhang et al. successfully applied this logic to a challenging clinical problem: distinguishing harmless fungal colonization from life-threatening pneumonia. By combining clinical risk stratification with a strict quantitative cutoff (>37 sequence reads), their framework allows clinicians to confidently identify active infections.
Host-Response Profiling
A more fundamental solution shifts the diagnostic focus away from the pathogen and onto the host. Instead of trying to filter out microbial noise mathematically, researchers look for biological proof of an ongoing battle. If a microbe is a harmless bystander, the host's immune system remains quiet; if it is an invader, the host activates specific molecular defenses.
Melissa Ross et al. validated this strategy in A comparison of host response strategies to distinguish bacterial and viral infection. By measuring a 45-gene host mRNA expression signature in the patient's blood, they could accurately determine whether a patient had an active bacterial or viral infection. Because this method measures the host's actual physiological response, it bypasses the colonization ambiguity entirely—offering a clear diagnostic signal even when pathogen-focused tests are swamped by background noise.
The Need for Standardization
While quantitative thresholds and host profiling offer clear paths forward, the widespread clinical adoption of molecular diagnostics is currently limited by a lack of uniformity. As argued by Fei Li et al. in Etiology of Severe Pneumonia in Children in Alveolar Lavage Fluid Using a High-Throughput Gene Targeted Amplicon Sequencing Assay, the absence of standardized interpretation criteria for high-throughput sequencing reads remains a major hurdle. Establishing universal, validated guidelines to separate background microbial noise from actionable infectious agents is the primary objective for the next generation of molecular diagnostics.
Key Foundational Work
Rare Detection of Occult Hepatitis B Virus Infection in Children of Mothers with Positive Hepatitis B Surface Antigen (2014) — contributed 1 concept elements to this direction.
Bacterial Microbiota Profiling in Gastritis without Helicobacter pylori Infection or Non-Steroidal Anti-Inflammatory Drug Use (2009) — contributed 1 concept elements to this direction.